(Q43830908)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753552%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Individually adjusted prophylactic donor lymphocyte infusions after CD34-selected allogeneic peripheral blood stem cell transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753552%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753552%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

Ferrá C

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753552%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Rodríguez-Luaces M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753552%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Encuentra M

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753552%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Martín-Henao GA

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753552%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Peris J

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753552%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Ancín I

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753552%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Sarrá J

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753552%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Berlanga JJ

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753552%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

García J

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753552%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Grañena A

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753552%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

language of work or name

English

0 references

publication date

1 November 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753552%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753552%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753552%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753552%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

963-968

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753552%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703277

5 December 2019

exact match

0 references

cites work

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703277

Prophylactic reinfusion of T cells for T cell-depleted allogeneic bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703277

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703277

The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703277

7 January 2021

Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703277

7 January 2021

CD34+ cell dose predicts relapse and survival after T-cell-depleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703277

7 January 2021

T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703277

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703277

7 January 2021

The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703277

7 January 2021

Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703277

7 January 2021

Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703277

7 January 2021

CD34 selected alloPBSCT and adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703277

7 January 2021

Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703277

7 January 2021

T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703277

7 January 2021

Use of recombinant human interleukin-2 in conjunction with bone marrow transplantation as a model for control of minimal residual disease in malignant hematological disorders: I. Treatment of murine leukemia in conjunction with allogeneic bone marro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703277

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703277

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11753552%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

5 December 2019

1048417494

0 references

1 reference